We use cookies to give you the best possible service. You can choose which cookies you would like us to set. Please note that depending on your settings, not all features of the page may be available. Further information can be found in our privacy policy.
IASON consulting assesses ecotoxicity data generated in studies following Good Laboratory Practices (GLPs) and internationally standardised guidelines provided by the Organisation for Economic Co-operation and Development (OECD) as a part of new marketing authorisation applications (MAA) for medicinal products and type II variations or line extensions.
IASON consulting has been offering full-service marketing authorisation support within the health science industry since 2004. Our one-stop shop services include guidance, review, scientific support, and the compilation of full or partial medicinal product applications, reviews, and reports for national and international approval of respective authorities such as EMA and FDA as well as for in-house use.
We gladly advise you regarding the necessity, preparation, and execution of your specific ERA according to guidelines as provided by, for example, the OECD (Organisation for Economic Co-operation and Development).